Frazis Capital Podcast
#92: Syntara Phase 2 Success, Geopolitics and Uranium
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:25:06
- Mas informaciones
Informações:
Sinopsis
Syntara’s highly anticipated Phase 2 results in myelofibrosis—what the data tells us, why the market sold off, and what might come next in terms of funding or partnership.
